EGFR and lung carcinoma: It has been reported that insulin-like growth factor 1 (IGF-1), the ligand of the IGF-1 receptor (IGF-1R), is highly expressed in the TME of the liver metastasis, and the signaling from IGF-1R promotes the tolerance to osimertinib in EGFR-positive lung cancer [40].